Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.89

+0.12 (+1.77%)

As of Aug 15, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -10.2% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $6.89

Current
$6.89

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-38.8%

Low target

Base Case

$6.19

-10.2%

Avg target

Bull Case

$8.57

+24.4%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$13.69

-49.7% from high

52-Week Low

$3.98

+73.1% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%